Evidence map›Paper›PMID 39968899›Full record

ReviewAutophagy2025

Lysosomal quality control Review.

Danielle Henn, Xi Yang, Ming Li

Abstract readReview
In one paragraph

Review in Autophagy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Review
  5. Review
  6. Article
  7. Contradictory Effects on Hepatocytes in ASMD.International journal of molecular sciences · 2026
    Review
  8. Article
  9. Review
  10. Article
  11. Review
  12. Review
  13. Review
  14. Review
  15. Article
  16. Article
  17. Review
  18. Lysosomal Repair in Health and Disease.Journal of cellular physiology · 2025
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Danielle HennDepartment of Molecular, Cellular, and Developmental Biology, University of Michigan, Ann Arbor, MI, USA.
Xi YangDepartment of Biological Sciences, Knoebel Institute for Healthy Aging, University of Denver, Denver, CO, USA.
Ming LiDepartment of Molecular, Cellular, and Developmental Biology, University of Michigan, Ann Arbor, MI, USA.ORCID 0000-0002-1247-2377

Funding

Characterization of TMEM251 that causes a new type of severe lysosome storage diseaseR01HD109346 · NICHD · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Ming Li · 2022 to 2026
$2.1M
Functional characterization of lysosome membrane and its protein quality control systemR35GM153356 · NIGMS · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Ming Li · 2024 to 2026
$1.2M
NICHD NIH HHS R01 HD109346NIGMS NIH HHS R35 GM153356
6 · The paper itself

Abstract

Healthy cells need functional lysosomes to degrade cargo delivered by autophagy and endocytosis. Defective lysosomes can lead to severe conditions such as lysosomal storage diseases (LSDs) and neurodegeneration. To maintain lysosome integrity and functionality, cells have evolved multiple quality control pathways corresponding to different types of stress and damage. These can be divided into five levels: regulation, reformation, repair, removal, and replacement. The different levels of lysosome quality control often work together to maintain the integrity of the lysosomal network. This review summarizes the different quality control pathways and discusses the less-studied area of lysosome membrane protein regulation and degradation, highlighting key unanswered questions in the field.

Indexed as

AutophagyLysosomesAnimalsHumansLysosomal Storage DiseasesESCRTlysophagylysosome membrane protein regulationlysosome membrane repairlysosome quality control

Identifiers

PMID39968899
PMCPMC12285598

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.